Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemo-Radiotherapy for High-Risk Head and Neck Cancer
NCT00006051Phase 2Completed
- Sponsor
- Unicancer
- Start
- Feb 1999
- Primary completion
- Aug 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cisplatin and fluorouracil in head and neck squamous cell carcinoma (HNSCC), sponsored by Unicancer. Primary endpoint: Toxicity. Started Feb 1999; status: completed.
02
Drugs
cisplatinfluorouracil
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00006051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006051.